Venture Capital INDUSTRIES

WilmerHale has extensive experience representing both venture-backed companies and venture capital firms in industries such as software, semiconductors and electronics, telecommunications and networking, life sciences and medical devices. Venture capital deals are a cornerstone of our corporate practice and reflect our long-standing focus on technology, life sciences and entrepreneurial companies. We have a strong presence in the venture capital community throughout the United States and Europe. We regularly serve as company counsel in venture financings and represent leading venture capitalists in fund formation and portfolio investments.

Our experience with venture-backed clients dates back to the rise of the computer industry in the early 1960s, when we incorporated some of the first technology startup companies, including Analog Devices, Prime Computer and Storage Technology. Since then, our practice has kept pace with the emergence of new technologies and industries: from mainframes in the 1960s to minicomputers in the 1970s; to software and biotech in the 1980s; to telecom, Internet and life sciences in the 1990s; and now to the most advanced technologies in nanotechnology, genomics, bioinformatics and countless other fields. Throughout this time we have advised leading companies in their formation, growth and eventual IPO or acquisition.

Today, emerging companies and leading venture capitalists throughout the United States and Europe continue to turn to WilmerHale for legal advice and business advantage. Hundreds of startup companies have relied on us from formation to funding to market leadership and successful IPOs or acquisitions. In 2013, we served as counsel in more than 300 venture financings raising approximately $2.5 billion, including some of the largest and most prominent deals of the year. Since 2004, we have handled more than 2,200 venture financings raising approximately $20 billion. With one of the top venture capital practices in the world, we are counsel to more venture capital-backed companies in the eastern half of the United States, and in Europe, than any other law firm.

Our extensive experience with VC-backed companies enables us to efficiently navigate the complexities of venture capital financings, as well as provide advice and insight to venture-backed clients as they build their businesses. Our startup company clients also benefit from the advice of our attorneys concentrating in intellectual property, labor and employment, environmental, litigation and real estate law, who have worked extensively with startup companies.

We have also represented venture capitalists for nearly four decades. At a time when many law firms were scarcely familiar with the concepts underlying venture financing, we assisted some of the earliest venture capital firms in their initial investments. Today we represent many premier US and European venture capital firms in portfolio investments.

Our practical, problem-solving approach and our collective experience, accumulated through our many years in the venture capital field, enable us to cost-effectively represent venture capitalists and VC-backed companies. In addition to our legal experience, we offer the advantage of technical and scientific knowledge and work experience from attorneys with degrees in fields such as biochemistry, biology, biomedical engineering, chemical engineering, chemistry, computer science, electrical engineering, genetics, immunology, information systems, mathematics, mechanical engineering, medicine, microbiology, organic chemistry and systems engineering. As a result, we have a sophisticated understanding of issues facing technology and life sciences companies.

Additional Venture Capital experience: 2014, 20132012, 2011, 2010, 2009, 2008, 2006, 2005, 2004, 2003, 2002, 2001

WilmerHale has extensive experience representing both venture-backed companies and venture capital firms in industries such as software, semiconductors and electronics, telecommunications and networking, life sciences and medical devices. Venture capital deals are a cornerstone of our corporate practice and reflect our long-standing focus on technology, life sciences and entrepreneurial companies. We have a strong presence in the venture capital community throughout the United States and Europe. We regularly serve as company counsel in venture financings and represent leading venture capitalists in fund formation and portfolio investments.

Our experience with venture-backed clients dates back to the rise of the computer industry in the early 1960s, when we incorporated some of the first technology startup companies, including Analog Devices, Prime Computer and Storage Technology. Since then, our practice has kept pace with the emergence of new technologies and industries: from mainframes in the 1960s to minicomputers in the 1970s; to software and biotech in the 1980s; to telecom, Internet and life sciences in the 1990s; and now to the most advanced technologies in nanotechnology, genomics, bioinformatics and countless other fields. Throughout this time we have advised leading companies in their formation, growth and eventual IPO or acquisition.

Read More

Contacts

Sort By
Bain, Mick

Mick Bain

Co-Chair, Emerging Company Practice

Co-Chair, Energy and Cleantech Group

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Buckland, Peter

Peter Buckland

Vice Chair, Corporate Practice Group

Co-Chair, Emerging Company Practice

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Publications & News

View

April 17, 2013

Selected 2013 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

February 20, 2013

Selected 2013 Venture Financings As Company Counsel

In 2012, we served as counsel in more than 200 venture financings raising approximately $1.5 billion, including some of the largest and most prominent deals of the year.

September 24, 2012

Legal 500 UK 2012 Recognizes WilmerHale’s London Offices

June 7, 2012

Chambers USA 2012 Final Results Announced

June 6, 2012

FBAR Deadline is June 29, 2012; IRS Form 8938 May Also Be Required

June 6, 2012

Selected 2012 Life Sciences Transactions

For more than four decades, we have represented life sciences clients in venture financings, public offerings, mergers and acquisitions, and licensing agreements and collaborations; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise-critical patent litigation; and navigated regulatory issues vital to their success.

June 4, 2012

2012 Venture Capital Report

April 13, 2012

Joshua Fox to be Featured at NYBA 21st Annual Meeting in NYC

March 27, 2012

Congress Passes New Capital Formation Legislation

March 1, 2012

Selected 2012 Venture Financings As Company Counsel

In 2011, we served as counsel in more than 200 venture financings raising over $1.5 billion, including some of the largest and most prominent deals of the year.